Chinese Journal of Pharmacovigilance ›› 2018, Vol. 15 ›› Issue (5): 314-315.
Previous Articles Next Articles
LIU Meng-xing ,CHEN Yong-gang ,LUO Ji ,WANG Jun-long ,SUN Hui ,CHEN Jie
Received:
2017-12-11
Revised:
2018-06-21
Online:
2018-05-20
Published:
2018-06-21
CLC Number:
LIU Meng-xing ,CHEN Yong-gang ,LUO Ji ,WANG Jun-long ,SUN Hui ,CHEN Jie. One Case of Severe Erythema Multiforme Drug Eruption Accompanied by Drug-induced Liver Injury Induced by Wikstroemiae indicae Radix Tablets [J]. Chinese Journal of Pharmacovigilance, 2018, 15(5): 314-315.
[1] 南京中医药大学.中药大辞典[M].2版.上海:上海科学技术出版社, 2006:68 -71. [2] 张立,喻文进,刘慧琼,等. 西瑞香素抗炎抑菌作用的初步实验研究[J]. 中医药导报,2012,18(6):72-73. [3] 熊友香,尤志勉,程东庆,等. 了哥王不同提取部位抑菌作用研究[J]. 中国中医药信息杂志,2008,15(10):42-43. [4] 薛 一. 了哥王细胞毒性和抗病毒活性成分研究[D].暨南大学,2007. [5] 柯雪红,王丽新,黄可儿. 了哥王片抗炎消肿及镇痛作用研究[J]. 时珍国医国药,2003,14(10):603-604. [6] 张鑫. 了哥王的化学成分及镇痛抗炎活性研究[D].广东药学院,2011. [7] 杨振宇,郭薇,吴东媛,等. 了哥王中西瑞香素的提取分离及抗肿瘤作用研究[J]. 天然产物研究与开发,2008,20(3):522-526. [8] 邵萌,黄晓君,孙学刚,等. 了哥王根茎中的酚性成分及其抗肿瘤活性研究[J]. 天然产物研究与开发,2014,26(6):851-855,875. [9] 李雨田,顾雪竹,张村. 了哥王的化学成分和药理作用研究进展[J]. 中国实验方剂学杂志,2011,17(24):252-255. [10] 赵华亮. 了哥王致红斑疹1例[J]. 中国药物滥用防治杂志,2007,13(1):55. [11] 李明桂. 中药了哥王致眼角膜灼伤1例[J]. 中国中医眼科杂志,1999,9(2):50. [12] 王志中.了哥王引起过敏性休克一例[J]. 河南赤脚医生,1981,(4):30. [13] 张庆文,余奕明,曾力生,等. 口服了哥王中毒致死1例[J]. 中国法医学杂志,2008,23(5):353. [14] 包振宇,邹先彪. 重症药疹的研究进展[J]. 实用皮肤病学杂志,2015,8(2):112-114,118. [15] 郭秀芝. 中草药过敏及毒性反应机理[J]. 山东医药工业,1998,17(5):50-51. [16] 林明宝. 中药引发过敏反应的危险因素及中成药致敏成分研究[D].浙江大学,2013. [17] 佟立今,孙立新,孙丽霞,等. 了哥王化学成分的分离与鉴定[J]. 中国药物化学杂志,2015,25(1):50-53. [18] 邵萌,黄晓君,孙学刚,等. 了哥王根茎中的酚性成分及其抗肿瘤活性研究[J]. 天然产物研究与开发,2014,26(6):851-855,875. [19] 易文燕,刘明,陈敏,等. 了哥王化学成分研究[J]. 时珍国医国药,2012,23(12):3001-3003. [20] 么焕开,仲英,尹俊亭. 了哥王的化学成分研究(Ⅰ)[J]. 中草药,2007,38(5):669-670. [21] 张金娟,熊英,张贵林,等. 了哥王提取物及其不同提取部位的急性毒性研究[J]. 时珍国医国药,2011,22(11):2829-2830. [22] 冯果,李玮,何新,等. 苗族药了哥王不同提取物对正常大鼠肝毒性的影响[J]. 中国实验方剂学杂志,2017,23(11):96-102. [23] 中华医学会肝病学分会药物性肝病学组.药物性肝损伤诊治指南(2015版)[J].中华肝脏病杂志,2015,23(11):810-820. [24] Martinez M A, Vuppalanchi R, Fontana R J, et al. Clinical and histologic features of azithromycin-induced liver injury[J].Clin Gastroenterol Hepatol, 2015, 13(2):369-376. |
[1] | SUN Qiyue, ZHAO Ronghua, GUO Shanshan, BAO Lei, GENG Zihan, LI Shuran, XU Yingli, ZHANG Jingsheng, CUI Xiaolan, SUN Jing. Multiple pharmacological effects of Lingyang Ganmao Oral Liquid [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 127-131. |
[2] | ZHAO Ronghua, SUN Jing, BAO Lei, GENG Zihan, TAO Xiali, ZHANG Jingsheng, PANG Bo, XU Yingli, CAO Shan, LI Shuran, GUO Shanshan, WANG Daohan, CUI Xiaolan. Mechanisms of Gegen Tang granules against viral pneumonia in mice based on immune regulation [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 132-136. |
[3] | BAO Lei, GENG Zihan, LI Shuran, JI Zuen, ZHAO Ronghua, SUN Jing, GUO Shanshan, CUI Xiaolan. The critical role of TRP channels in the progression of viral pneumonia [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 137-140. |
[4] | JIA Jinsheng, LIU Hongliang, WANG Qing, HOU Yongfang, LI Xinling. Evaluation of the relevance of adverse drug reaction based on ERNIE-DPCNN [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 163-166. |
[5] | LI Jiaxin, LIU Huimin, QIAN Wenxiu, MA Ning, SONG Lili, LI Yubo. Nephrotoxic effects and usage of traditional Chinese medicines based on the Traditional Chinese Medicine Systems Toxicology Database [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 173-180. |
[6] | FAN Kaikai, WANG Cong, LIU Hongfeng, WANG Xiyong. Effects of clinical pharmacist interventions on usage of alanyl-glutamine injections in a hospital [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 181-184. |
[7] | ZHANG Jian, FANG Huihua. Applicability of evaluation standards for use of traditional Chinese medicine injections for promoting blood circulation and removing blood stasis [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 185-189. |
[8] | WANG Shan, XIE Bo, LIU Huimin, LI Zhihao. Adverse event signals for celecoxib based on FAERS database [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 190-194. |
[9] | LI Yingfen, HAN Lei. Analysis of 319 cases of adverse drug reaction induced by cerebroprotein hydrolysate for injection [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 195-198. |
[10] | XU Weijia, PENG Qi, HUANG Haiyu, ZHANG Leijiao, XIAO Hua, WU Xue. 285 cases of adverse drug reaction related to new antineoplastic drugs [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 199-203. |
[11] | GUO Qinghua, PENG Xiaoxiao, ZHU Ping, LIU Xilin, YANG Yinghua, CHEN Zhihai. One case of multiple organ dysfunction syndrome caused by amlodipine overdose [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 204-207. |
[12] | FANG Meilin, ZHENG Huimin, WANG Cunze, WANG Ling, RUAN Junshan. One case of generalized myalgia caused by oxaliplatin [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 208-210. |
[13] | LI Na, GUO Jun, GUO Wenjia, LYU Yinyin, LI Caihong, MU Xiangdong. One case of delayed skin allergic reaction caused by asthma treated with omalizumab injection [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 211-212. |
[14] | CAO Guiping, DENG Linlin, ZHU Ganhong, LU Ying, MA Shuang, CHEN Linlin, Liu Lili. One case of severe liver injury caused by Tianma Shouwu tablets [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 216-218. |
[15] | ZHU Ying, SHEN Lu, LI Lan, WU Jianmin, GAO Xiaojie. Adverse reaction monitoring of toothpaste in China under the new regulatory system [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 219-222. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||